Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 5
2006 1
2007 2
2008 5
2009 10
2010 13
2011 15
2012 14
2013 14
2014 11
2015 25
2016 27
2017 21
2018 16
2019 18
2020 12
2021 26
2022 17
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma.
Rey V, Tornín J, Alba-Linares JJ, Robledo C, Murillo D, Rodríguez A, Gallego B, Huergo C, Viera C, Braña A, Astudillo A, Heymann D, Szuhai K, Bovée JVMG, Fernández AF, Fraga MF, Alonso J, Rodríguez R. Rey V, et al. Among authors: bovee jvmg. EBioMedicine. 2024 Apr;102:105090. doi: 10.1016/j.ebiom.2024.105090. Epub 2024 Mar 27. EBioMedicine. 2024. PMID: 38547578 Free PMC article.
Multimodal profiling of chordoma immunity reveals distinct immune contextures.
van Oost S, Meijer DM, Ijsselsteijn ME, Roelands JP, van den Akker BEMW, van der Breggen R, Briaire-de Bruijn IH, van der Ploeg M, Wijers-Koster PM, Polak SB, Peul WC, van der Wal RJP, de Miranda NFCC, Bovee JVMG. van Oost S, et al. Among authors: bovee jvmg. J Immunother Cancer. 2024 Jan 25;12(1):e008138. doi: 10.1136/jitc-2023-008138. J Immunother Cancer. 2024. PMID: 38272563 Free PMC article.
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
Koch R, Haveman L, Ladenstein R, Brichard B, Jürgens H, Cyprova S, van den Berg H, Hassenpflug W, Raciborska A, Ek T, Baumhoer D, Egerer G, Kager L, Renard M, Hauser P, Burdach S, Bovee JVMG, Hong AM, Reichardt P, Kruseova J, Streitbürger A, Kühne T, Kessler T, Bernkopf M, Butterfaß-Bahloul T, Dhooge C, Bauer S, Kiss J, Paulussen M, Bonar F, Ranft A, Timmermann B, Rascon J, Vieth V, Kanerva J, Faldum A, Hartmann W, Hjorth L, Bhadri VA, Metzler M, Gelderblom H, Dirksen U. Koch R, et al. Among authors: bovee jvmg. Clin Cancer Res. 2023 Dec 15;29(24):5057-5068. doi: 10.1158/1078-0432.CCR-23-1966. Clin Cancer Res. 2023. PMID: 37843857 Clinical Trial.
VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation.
Luk SJ, Schoppmeyer R, Ijsselsteijn ME, Somarakis A, Acem I, Remst DFG, Cox DT, van Bergen CAM, Briaire-de Bruijn I, Grönloh MLB, van der Meer WJ, Hawinkels LJAC, Koning RI, Bos E, Bovée JVMG, de Miranda NFCC, Szuhai K, van Buul JD, Falkenburg JHF, Heemskerk MHM. Luk SJ, et al. Among authors: bovee jvmg. Cancer Immunol Res. 2023 Nov 1;11(11):1480-1492. doi: 10.1158/2326-6066.CIR-22-0759. Cancer Immunol Res. 2023. PMID: 37695550
Histological response to radiotherapy is an early event in myxoid liposarcoma.
Lam SW, Silva TM, Traast-Kooistra J, Bruijn IB, van den Akker B, Bakker PAC, Lansu J, Haas RLM, Bovée JVMG. Lam SW, et al. Among authors: bovee jvmg. Virchows Arch. 2023 Oct;483(4):487-495. doi: 10.1007/s00428-023-03615-5. Epub 2023 Aug 12. Virchows Arch. 2023. PMID: 37572156 Free PMC article.
Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors.
Stelloo E, Meijers RWJ, Swennenhuis JF, Allahyar A, Hajo K, Cangiano M, de Leng WWJ, van Helvert S, Van der Meulen J, Creytens D, van Kempen LC, Cleton-Jansen AM, Bovee JVMG, de Laat W, Splinter E, Feitsma H. Stelloo E, et al. Among authors: bovee jvmg. J Mol Diagn. 2023 Oct;25(10):758-770. doi: 10.1016/j.jmoldx.2023.06.012. Epub 2023 Jul 28. J Mol Diagn. 2023. PMID: 37517473 Free article.
IDH Mutations in Chondrosarcoma: Case Closed or Not?
Venneker S, Bovée JVMG. Venneker S, et al. Among authors: bovee jvmg. Cancers (Basel). 2023 Jul 13;15(14):3603. doi: 10.3390/cancers15143603. Cancers (Basel). 2023. PMID: 37509266 Free PMC article. Review.
Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
Kalisvaart GM, Van Den Berghe T, Grootjans W, Lejoly M, Huysse WCJ, Bovée JVMG, Creytens D, Gelderblom H, Speetjens FM, Lapeire L, van de Sande MAJ, Sys G, de Geus-Oei LF, Verstraete KL, Bloem JL. Kalisvaart GM, et al. Among authors: bovee jvmg. Skeletal Radiol. 2024 Feb;53(2):319-328. doi: 10.1007/s00256-023-04402-8. Epub 2023 Jul 18. Skeletal Radiol. 2024. PMID: 37464020 Free PMC article.
No NFATC2 fusion in simple bone cyst of the jaw.
Ong SLM, Gomes IP, Baelde HJ, Passador-Santos F, de Andrade BAB, Briaire-de Bruijn IH, Cavalcante IL, Schreuder WH, Cleton-Jansen AM, Cleven AHG, Szuhai K, Gomes CC, Bovée JVMG. Ong SLM, et al. Among authors: bovee jvmg. Histopathology. 2023 Aug;83(2):326-329. doi: 10.1111/his.14905. Epub 2023 Mar 20. Histopathology. 2023. PMID: 36939112
Psammomatoid Ossifying Fibroma Is Defined by SATB2 Rearrangement.
Cleven AHG, Szuhai K, van IJzendoorn DGP, Groen E, Baelde H, Schreuder WH, Briaire-de Bruijn IH, van der Meeren SW, Kleijwegt MC, Furth WR, Kroon HM, Suurmeijer AJH, Savci-Heijink DC, Baumhoer D, Bovée JVMG. Cleven AHG, et al. Among authors: bovee jvmg. Mod Pathol. 2023 Jan;36(1):100013. doi: 10.1016/j.modpat.2022.100013. Mod Pathol. 2023. PMID: 36788065
233 results